Fact CheckerSign in

NCT05371977Recruiting

Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma

Source: ClinicalTrials.gov · Last updated 15 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to assess whether deep sclerectomy is as effective in lowering intraocular pressure (IOP) as trabeculectomy in patients with normal tension glaucoma.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
2 May 2022
Start date
31 May 2022
Primary completion date
May 2026
Lead sponsor
Helsinki University Central Hospital
Diseases
Glaucoma
NCT number
NCT05371977

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 31 May 2022 to the primary completion date, May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Secondary Glaucoma e.g. due to previous injury or uveitis
  • Previous transscleral or endoscopic cyclophotocoagulation
  • Previous other glaucoma surgery
  • Previous retinal detachment
  • Previous intraocular surgery like vitrectomy and other retinal surgery
  • Previous corneal transplant or previous refractive surgery

Other illness

  • Exfoliation syndrome
  • Pigment dispersion syndrome
  • Dementia

Age

  • Wet age-related macular degeneration

Other

  • Diabetic retonopathy
  • Fuchs' dystrophy and other abnormalities compromising corneal clarity like scars
  • The patient does not want to participate in the study
  • The patient does not speak Finnish, Swedish or English
  • Only eye with vision worse than 20/200 or loss of central visual field

Who the study is looking for

  • Signed Informed Consent
  • Normal Tension Glaucoma with typical nerve fiber layer defects in red-free photographs and/or optical coherence tomography (OCT) and possible equivalent visual field defects, IOP never more than 21 mmHg, and open anterior chamber angle
  • Glaucoma unstable with current medication assessed by a glaucoma specialist

Age in the registry: 55 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Helsinki University Central Hospital
Coordinator of this site? Confirm its status
HelsinkiFinlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.